Newsletter Archive

  1. 08.31.16 -- Data Integrity: Surveying The Current Regulatory Landscape
    8/31/2016

    08/31/16 BioProcess Online Newsletter

  2. 08.29.16 -- CAR T-Cell Therapy: The Road Ahead
    8/29/2016

    08/29/16 Bioprocess Online Newsletter

  3. 08.24.16 -- Manage QMS Disparities Between Drugs And Devices For Combo Products
    8/24/2016

    08/24/16 BioProcess Online Newsletter

  4. 08.22.16 -- Can You Support Quality Metrics With Lobotomized Data?
    8/22/2016

    08/22/16 BioProcess Online Newsletter

  5. 08.17.16 -- Bioprocess Facility Design: Layout Rules & Configurations
    8/17/2016

    08/17/16 BioProcess Online Newsletter

  6. 08.15.16 -- Biosimilars Pipeline Analysis: More Products, Competition Coming
    8/15/2016

    08/15/16 BioProcess Online Newsletter

  7. 08.10.16 -- How Brexit Impacts Pharma Market Authorization & Pricing
    8/10/2016

    08/10/16 BioProcess Online Newsletter

  8. 08.08.16 -- Analysis Of Recent CDER Observation & Warning Letter Data
    8/8/2016

    08/08/16 BioProcess Online Newsletter

  9. 08.03.16 -- Brexit's Impact On Global Pharma Industry
    8/3/2016

    08/03/16 BioProcess Online Newsletter

  10. 08.01.16 -- Are You Prepared For The EU's Falsified Medicines Directive?
    8/1/2016

    08/01/16 BioProcess Online Newsletter